Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
申请人:ELI LILLY AND COMPANY
公开号:EP0708179A2
公开(公告)日:1996-04-24
Glucagon-like insulinotropic peptide (GLP-1(7-37)) analogs and derivatives are disclosed. The analogs include amino acid substitutions, amino and carboxyl terminal modifications, and C₆-C₁₀ acylations. The claimed compounds stimulate the secretion or biosynthesis of insulin in poorly functioning beta cells and are therefore useful in treating Type II diabetics
本研究公开了胰高血糖素样促胰岛素肽(GLP-1(7-37))类似物和衍生物。这些类似物包括氨基酸取代、氨基和羧基末端修饰以及 C₆-C₁₀酰化。这些化合物能刺激功能不佳的β细胞分泌或生物合成胰岛素,因此可用于治疗 II 型糖尿病患者。